Skip to main content

Advertisement

Table 1 Factors Affecting Complete Eradication of Intestinal Metaplasia

From: Length of Barrett’s segment predicts failure of eradication in radiofrequency ablation for Barrett’s esophagus: a retrospective cohort study

  All Patientsa Complete Eradication of Intestinal Metaplasia Incomplete Eradication of Intestinal Metaplasia  
  107 100.0% 61 57.0% 46 43.0% p-valueb
Patient Characteristic
Race
 White 103 96.3% 59 96.7% 44 95.7% 0.773
 Other 4 3.7% 2 3.3% 2 4.3%
Sex
 Male 93 86.9% 51 83.6% 40 86.9% 0.242
 Female 14 13.1% 10 16.4% 6 13.1%
 Age c64 (58-72) c 63 (57–72) c 67 (59–76) 0.117
 BMI c 29.1 (25.5–32.6) c 30.9 (26.5–33.1) c 28.3 (24.5–30) 0.077
Dysplasia
 HGD 44 41.1% 24 39.3% 20 43.5% 0.667
 LGD 63 58.9% 37 60.7% 26 56.5%
Comorbidities
 GERD 75 70.1% 30 49.2% 32 69.6% 0.339
 Hyperlipidemia 26 24.3% 17 27.9% 11 23.9% 0.322
 Diabetes 25 23.4% 15 24.6% 10 21.7% 0.730
 Hypertension 59 55.1% 30 49.2% 31 67.4% 0.154
History of Tobacco Usage
 Yes 60 56.1% 30 49.2% 29 63.0% 0.225
 No 33 30.8% 21 34.4% 13 28.3%
 Unknown 14 13.1% 10 16.4% 4 8.7%
Endoscopic Treatments Received
 EMR 24 22.4% 16 26.2% 8 17.4% 0.326
Length
 Median, IQR 5 (2–7) 3 (2–7) 7 (2–8) < 0.001
 </= 5 cm 64 59.8% 44 72.1% 20 43.4% < 0.001
  > 5 cm 43 40.2% 17 27.9% 26 56.6%
Number of RFA’s
Median, IQR 3 (2–5) 3 (2–5) 4 (2–5) 0.023
  ≤ 3 62 57.9% 41 67.2% 21 45.7% 0.008
  >  3 45 42.1% 20 32.8% 25 54.3%
  1. aData presented as N (%) or median (IQR)
  2. bp-value ≤0.05 is significant
  3. caverage; not total number of patients